
Product Details
Product Name: MT-2 Human Lymphoma Cell Line | CAS No.: 121062-08-6 |
Min. Order: 1g | Purity: 99% |
Supply Ability: 1 tons | Release date: 2025/10/15 |
CAS No.:121062-08-6
Formula: C50H69N15O9
Key Specification:
Appearance: White powder
Purity (HPLC) ≥99.0%
Package:
Vacuum packaging in aluminum foil bags, plastic bottles or transparent bags. 10mg, 50mg, 100mg, 1g, 10g, 50g per package, with ice packs. Or customized according to your requirements.We sell to customers worldwide.
Company Profile Introduction
Hangzhou Taisheng Pharmaceutical Technology Co., Ltd. is a biotech company located in Xiasha Qiantang New Area, Hangzhou, specializing in the research and production of peptide products. Founded in 2023, the founder and its team have been engaged in peptide research and production for more than ten years. At present, the company has a peptide R&D center in Hangzhou, with multiple complete peptide production lines, a number of sets of large-scale peptide synthesis equipment, imported HPLC analysis and preparation equipment, and a clean laboratory that meets GMP standards.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$65.00/5mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-10-17 | |
$50.00/1box |
VIP1Y
|
GUANGZHOU SHENGYOU IM&EX CO,.LTD
|
2025-10-15 | |
$20.00/1box |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2025-10-13 | |
$0.00/1box |
VIP1Y
|
Shanghai Yimeixin Technology Co., LTD
|
2025-09-26 | |
$50.00/1box |
VIP1Y
|
Hebei Lutong Import and Export Co., Ltd
|
2025-09-25 | |
$49.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-09-16 | |
$5.00/1Box |
VIP1Y
|
Hebei Jiafan Trading Company Limited
|
2025-07-24 | |
$0.00/1g |
VIP4Y
|
Wuhan Biocar Pharmacy CO.,Ltd.
|
2025-07-15 | |
$1.00/10mg |
VIP1Y
|
Handan City Zechi trading Co., LTD
|
2025-07-02 | |
$0.00/10vials |
VIP1Y
|
Zhengzhou Yichi Technology Co., Ltd
|
2025-06-11 |
- Since: 2023-12-08
- Address: Room 102, South of 1st Floor, Building 1, No. 398 Haida North Road, Xiasha Street, Qiantang District
INQUIRY